Cell (19 companies)

Ticker	Company	Therapeutic areas	Programs	Lead stage	Programs
ALLO	Allogene Therapeutics, Inc.	ImmunologyOncology Rare	12	Phase 2	12
ARTV	Artiva Biotherapeutics, Inc.	DermatologyImmunologyOncologyRenal Rare	16	Phase 2	16
BEAM	Beam Therapeutics Inc.	HematologyMetabolicRespiratory Rare	2	Phase 1	8
BCTX	BriaCell Therapeutics Corp.	Oncology	6	Phase 3	8
CABA	Cabaletta Bio, Inc.	DermatologyImmunologyNeurologyRenal Rare	8	Phase 1	8
CRBU	Caribou Biosciences, Inc.	ImmunologyOncology	3	Phase 3	4
IPSC	Century Therapeutics, Inc.	ImmunologyMetabolicRenal Rare	10	Phase 1	11
FBIO	Fortress Biotech, Inc.	DermatologyHematologyMetabolic Rare	1	Approved	14
IMTX	Immatics N.V.	Oncology	2	Phase 2	8
IMMX	Immix Biopharma, Inc.	Hematology Rare	1	Phase 2	1
IBRX	ImmunityBio, Inc.	Infectious DiseaseOncology	6	Approved	17
INAB	IN8BIO, INC.	ImmunologyOncology	5	Phase 2	6
KYTX	Kyverna Therapeutics, Inc.	ImmunologyNeurologyRenal Rare	7	NDA Submitted	7
LGVN	Longeveron Inc.	CardiovascularMetabolicNeurology Rare	4	Phase 2	4
MRKR	Marker Therapeutics, Inc.	Oncology	4	Phase 1	4
OCGN	Ocugen, Inc.	Infectious DiseaseOphthalmology Rare	1	Phase 3	13
TARA	Protara Therapeutics, Inc.	DermatologyMetabolicOncology Rare	2	Phase 3	3
SANA	Sana Biotechnology, Inc.	MetabolicOncology	2	Phase 1	5
VOR	Vor Biopharma Inc.	ImmunologyNeurologyOncology Rare	2	Phase 3	4